drugset / Trial / NCT05690932
A Formulation Bridging and Food Effect Study of PBI-200 in Healthy Volunteers
RandomizedCrossoverOpen-labelTreatment
Summary
This is a single-dose, two-part, crossover formulation bridging and food effect study to assess the effect of formulation and food on the absorption and bioavailability of PBI-200 in normal, healthy volunteers.
Timeline
- Start
- 2022-02-24
- Primary completion
- 2022-05-23
- Completion
- 2022-05-23
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | PALTIMATRECTINIB | Small molecule | — | — |
Indications
No indication recorded.